BackHims & Hers Health Overview
Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Target Price

Analysts' 12-month price predictions for HIMS.

Share Price

$53.61

Average Target Price

$68.0026.8% upside

1 analysts in the last 4 months

High: $68 | Low: $68

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-02-19Canaccord GenuityMaria Ripps$6826.8% upsideOpen
2024-12-02Canaccord GenuityMaria Ripps$3829.1% downsideOpen
2024-11-05Piper SandlerKorinne Wolfmeyer$2160.8% downsideOpen
2024-11-05NeedhamRyan MacDonald$2847.8% downsideOpen
2024-10-29Leerink PartnersMichael Cherny$2651.5% downsideOpen
2024-10-21Bank of America SecuritiesMichael Cherny$2553.4% downsideOpen
2024-10-14Bank of America SecuritiesMichael Cherny$2357.1% downsideOpen
2024-10-14Truist FinancialJailendra Singh$2357.1% downsideOpen
2024-09-13Bank of America SecuritiesAllen Lutz$2062.7% downsideOpen
2024-08-27CitigroupDaniel Grosslight$2062.7% downsideOpen
2024-08-07JefferiesGlen Santangelo$1866.4% downsideOpen
2024-08-06Deutsche BankGeorge Hill$2357.1% downsideOpen
2024-05-22Canaccord GenuityMaria Ripps$2455.2% downsideOpen
2024-05-07JefferiesGlen Santangelo$1473.9% downsideOpen
2024-05-07Truist FinancialJailendra Singh$1375.8% downsideOpen
2024-05-07Piper SandlerKorinne Wolfmeyer$1375.8% downsideOpen
2024-05-07Deutsche BankGeorge Hill$1670.2% downsideOpen
2024-04-16JefferiesGlen Santangelo$1572% downsideOpen
2024-04-10Canaccord GenuityMaria Ripps$2062.7% downsideOpen
2022-08-10Credit Suisse$885.1% downsideOpen
2022-08-09Leerink Partners$590.7% downsideOpen
2022-05-26Piper Sandler$688.8% downsideOpen